The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

Previous | 2024 Agenda and Abstracts | Next

 

2024 OMIG Abstract

Seasonal Hyperacute Panuveitis (SHAPU) is associated with Streptococcus pneumonia infection

Kenji Nakamichi1, S Shreshtha2, M Sundararajan1, B Karmacharya2, M Poudel2, R Upreti2, AR Maharjan2,
P Banjara2, A Shreshtha3, A Sandt1, G Turski1, E Buhr1, A Chowdhary1, A Manandhar2*, RN Van Gelder1


1Department of Ophthalmology and Karalis Johnson Retina Center, University of Washington School of Medicine, Seattle, WA; 2Tilganga Eye Hospital, Kathmandu, Nepal; 3Dulikhal Hospital, Dulikhal, Nepal


Purpose: To survey vitreous biopsy samples from patients with SHAPU for presence of potential pathogens using metagenomic DNA sequencing.

Methods: DNA was extracted from vitreous biopsy of 53 subjects with SHAPU and was sequenced using nanopore long read sequencing and analyzed using the Scalable Metagenomics Analysis Research Tool (SMART).

Results: Adequate DNA was obtained from 32 samples. 15 samples yielded bacteria on culture, with 14 S. pneumonia and one Staph isolate recovered. DNA was detected by whole genome sequencing in 29/32 cases. S. pneumonia was recovered as the predominant organism in all but one sample. Bacterial loads ranged up to 10,000 bacteria/human cell indicating active infection. No pathogens were detected in control samples. Visual outcomes were mixed, with seven patients having hypotonus eyes at 6 months but 8 patients having better than 20/200 vision. No relationship could be discerned between initial bacterial load and visual outcome.

Conclusions: The majority of SHAPU cases show molecular evidence for concurrent S. pneumonia infection. Good visual results are possible in treating SHAPU as endophthalmitis.


Disclosure:

N

Support:
RPB and the Mark J. Daily research fund


Previous | 2024 Agenda and Abstracts | Next

 


 

 

space